Defiance Daily Target 2X Long NVO ETF (NVOX)

NYSEARCA: NVOX · Real-Time Price · USD
23.23
-0.11 (-0.47%)
Dec 26, 2025, 4:00 PM EST - Market closed
-0.47%
Assets$100.21M
Expense Ratio1.30%
PE Ration/a
Shares Out4.28M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume615,949
Open23.89
Previous Close23.34
Day's Range22.64 - 23.89
52-Week Low16.08
52-Week High105.60
Betan/a
Holdings11
Inception DateDec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NYSEARCA
Ticker Symbol NVOX
ETF Provider Defiance

Top 10 Holdings

270.00% of assets
NameSymbolWeight
US DOLLARSn/a68.31%
NOVO-NORDISK SWAP MSn/a48.69%
NOVO-NORDISK A/S-SPONS ADR NOMURAn/a33.31%
NOVO-NORDISK SWAP CLEARSTREETn/a32.65%
NOVO-NORDISK SWAP MAREXn/a32.58%
NOVO-NORDISK INC SWAP CANTORn/a31.43%
NOVO-NORDISK SWAP BMO-Ln/a17.94%
United States Treasury Bills 0%B.0 01.15.264.78%
First American Government Obligations FundFGXXX2.20%
OTHER ASSETS AND LIABILITIESn/a-1.88%
View More Holdings

Performance

NVOX had a total return of -76.09% in the past year, including dividends. Since the fund's inception, the average annual return has been -84.34%.

News

Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk

MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss marke...

Other symbols: NVO
1 year ago - GlobeNewsWire